Preclinical Evaluation of Lipid-Based Nanosystems |
Autore | Silva Ana Catarina |
Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
Descrizione fisica | 1 electronic resource (351 p.) |
Soggetto topico | Technology: general issues |
Soggetto non controllato |
nanostructured lipid carriers (NLC)
formulation optimization rivastigmine quality by design (QbD) nasal route nose-to-brain N-alkylisatin liposome urokinase plasminogen activator PAI-2 SerpinB2 breast cancer liposomes target delivery nanosystem FZD10 protein colon cancer therapy supersaturation silica-lipid hybrid spray drying lipolysis lipid-based formulation fenofibrate mesoporous silica oral drug delivery hyaluronic acid drug release light activation stability mobility biocorona dissolution enhancement phospholipids solid dosage forms porous microparticles nanoemulsion(s) phase-behavior DoE D-optimal design vegetable oils non-ionic surfactants efavirenz flaxseed oil nanostructured lipid carriers nanocarrier docohexaenoic acid neuroprotection neuroinflammation fluconazole Box‒Behnken design nanotransfersome ulcer index zone of inhibition rheological behavior ex vivo permeation nanomedicine cancer doxorubicin melanoma drug delivery ultrasound contrast agents phospholipid coating ligand distribution cholesterol acoustic response microbubble lipid phase dialysis ammonia intoxication cyanocobalamin vitamin B12 atopic dermatitis psoriasis transferosomes lipid vesicles skin topical delivery oligonucleotide self-emulsifying drug delivery systems hydrophobic ion pairing intestinal permeation enhancers Caco-2 monolayer clarithromycin solid lipid nanoparticles optimization permeation pharmacokinetics follicular targeting dexamethasone alopecia areata lipomers lipid polymer hybrid nanocapsules biodistribution skin ethyl cellulose |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910557544303321 |
Silva Ana Catarina
![]() |
||
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
The Role of Fibrinolytic System in Health and Disease |
Autore | Kwaan Hau C |
Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
Descrizione fisica | 1 electronic resource (170 p.) |
Soggetto topico |
Research & information: general
Biology, life sciences |
Soggetto non controllato |
COVID-19
fibrinolysis renin-aldosterone-angiotensin-system (RAAS) plasminogen activator inhibitor 1 (PAI-1) urokinase plasminogen activator urokinase plasminogen activator receptor plasminogen activator inhibitor-1 acute lung injury and repair and pleural injury and pleural organization PAI-1 cardiovascular disease cancer inflammation fibrosis aging obstructive sleep apnoea OSA coagulation platelets brown adipose tissue obesity plasminogen activation immune response thrombin activatable fibrinolysis inhibitor TAFI proCPU proCPB proCPR carboxypeptidase uPA uPAR PA system tissue-type plasminogen activator (tPA) urokinase-type plasminogen activator (uPA) neurodegeneration thrombin shear clot retraction Factor XIII clot stability NETs plasmin plasminogen activator PAI-2 antiplasmin |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910580213103321 |
Kwaan Hau C
![]() |
||
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|